Dr. Scott Gottlieb on concerns over drug trials in China

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the FDA's selection of seven companies for its PreCheck Pilot Program, concerns over drug trials in China, and more ...
American Enterprise Institute

Discussing GLP-1’s and the drug approval process: Gottlieb on CNBC’s “Squawk Box”

Senior Fellow Scott Gottlieb discusses GLP-1’s and the drug approval process: Gottlieb on CNBC’s “Squawk Box.” ...
American Enterprise Institute

Discussing the FDA’s new rare disease framework: Gottlieb on CNBC’s ‘Squawk Box’

Senior Fellow Scott Gottlieb discusses the FDA’s new rare disease framework on CNBC’s ‘Squawk Box.’ ...
American Enterprise Institute

Discussing concerns over the shift of drug trials to China and the FDA’s new PreCheck program: Gottlieb on CNBC’s ‘Squawk Box’

Senior Fellow Scott Gottlieb discusses concerns over the shift of drug trials to China and the FDA’s new PreCheck program on CNBC’s ‘Squawk Box.’ ...
American Enterprise Institute

Discussing the latest on the hantavirus outbreak and the FDA’s updated policies on vaping devices: Gottlieb on CNBC’s ‘Squawk Box’

Senior Fellow Scott Gottlieb discusses the latest on the hantavirus outbreak, developments at the FDA, and the agency’s updated policies on vaping devices on CNBC’s ‘Squawk Box.’ ...
CNBC

Larger trials likely needed to prove Tylenol, Autism risk correlation: Dr. Scott Gottlieb

CNBC’s “Squawk Box” team discusses the Washington Post's reporting that the Trump administration is planning to tie Tylenol use during pregnancy to the risk of Autism with Dr. Scott Gottlieb, CNBC ...
American Enterprise Institute

Discussing possible updates to the childhood vaccine schedule and new drug pricing proposals: Gottlieb on CNBC’s ‘Squawk Box’

Senior Fellow Scott Gottlieb discusses possible updates to the childhood vaccine schedule and new drug pricing proposals on CNBC’s ‘Squawk Box.’ ...
American Enterprise Institute

Discussing the latest developments in the Ebola outbreak and FDA management changes: Gottlieb on CNBC’s ‘Squawk Box’

Senior Fellow Scott Gottlieb discusses the latest developments in the Ebola outbreak in West Africa and FDA management changes on CNBC’s ‘Squawk Box.’ ...
American Enterprise Institute

Discussing the rapid expansion of CAR-T therapies and efforts to streamline FDA approvals for next-gen treatments: Gottlieb on CNBC’s ‘Sqauwk Box’

Senior Fellow Scott Gottlieb discusses the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments ...
CNBC

Dr. Scott Gottlieb: FDA's rare disease framework is 'a very good start'

Dr. Scott Gottlieb: FDA's rare disease framework is 'a very good start' Former FDA Commissioner Dr. Scott Gottlieb joins "Squawk Box' to discuss the FDA's new framework for accelerating the ...